Tag: CDC and FDA recommend pause J&J vaccine

CDC Advisory Committee on Immunization Practices Meeting October 20-21

I’m not sure what the announcement for the Advisory Committee on Immunization is all about for October 20, 21, 2021. It’s supposed to have 2 pages for the agenda and I see only one. The date in the agenda heading is “October 14, 2021” and the agenda has two dates: one for October 20 which is not about COVID-19 vaccine boosters and one for October 21 which says “Coronavirus Disease 2019 (COVID-19) Vaccines TBD.”

I suspect the ACIP will be discussing the Moderna and J&J vaccine boosters, which is what would follow the FDA advisory committee meeting decisions on October 14, 15.

Update: CDC Emergency Meeting June 23-25, 2021 on COVID-19 Vaccine Safety Including Myocarditis

The CDC Advisory Committee on Immunization Practices (ACIP) emergency meeting is re-scheduled for June 23-25, 2021 to discuss COVID-19 vaccine safety including myocarditis after Vaccine Safety Technical Work Group assessment. You can find a webcast link and the draft of the working agenda details here. The Vaccines and Related Biological Products Advisory Committee report slide set summary as of May 31, 2021 is on slide 26. The American Academy of Pediatrics (AAP) news story is here.

FDA and CDC Lift Pause on J&J COVID-19 Vaccine

After a safety review today, the FDA and CDC lifted the pause on the Johnson & Johnson COVID-19 vaccine. See the full announcement on the FDA website.

CDC Update on Pause of Johnson & Johnson Covid-19 Vaccine

The CDC is updating information about the pause in administration of the Johnson & Johnson COVID-19 vaccine because of a small number of reported cases of rare and severe blood clots after receiving the vaccine. See the link here for updates as new information becomes available. You can also find the updates page in the menu link above titled “CDC GUIDANCE COVID-19 VACCINES.” I’ll stick this post to the top of the blog for now.

The CDC web page about this issue offers important guidance for health care professionals and patients.

See the video below from the University of Iowa for more information:

CDC and FDA Recommend Pause of Johnson & Johnson Vaccine

The CDC and FDA issued a joint statement about pausing the Johnson & Johnson Covid-19 vaccine on April 13, 2021 because of concerns about rare but serious blood clots associated with it. See the FDA YouTube below for more information. There will be a meeting today of the Advisory Committee on Immunization Practices (ACIP) to review the cases and assess further significance. The Iowa Department of Public Health has recommended that all agencies pause administration of the Johnson & Johnson vaccine. The recommendation is being followed, comments by University of Iowa Health Care experts are reported in the Daily Iowan. The CDC has posted a Health Alert Network notice.

%d bloggers like this: